Results - Announcements
Cipla Ltd share price gained 1.20% to Rs 1353.0 after the company's net profit grew slightly 8.82% to Rs 856.52 crore, while revenue from operations improved marginally 4.11% to Rs 7368.15 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, rising 3.34%. It has marginally improved by 0.07% over last one week and softened by 3.01% in last one month while the market capitalization of Cipla Ltd has improved by 1.65% and 8.17% in the same period respectively.
Profit before tax (PBT) of Cipla Ltd stood at Rs 1177.34 crore in Q3 FY26, plunging by 36.48% year-on-year, and gaining 8.82% quarter-on-quarter. EBITDA came in at Rs 1237 crore, tumbling by 23.94% YoY and expanding by 26.01% sequentially.
Total expenses inched up 2.08% to Rs 6361.01 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1523.74 crore, going up by 12.29% YoY, while employee benefits expense was at Rs 1474.61 crore, slipping by 1.52% YoY.
For the TTM ended FY26, revenue from operations inched higher 2.09% to Rs 27711.69 crore, while net profit plunged by 26.86% to Rs 3869.79 crore, compared to previous TTM. EBITDA surged by 636906% to Rs 5000.89 crore, and PBT tanked by 23.42% to Rs 5223.63 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 3940.02 crore in FY26, as against Rs 5004.98 crore in FY25.
Cipla Ltd tumbled by 14.58% in last one year, significantly underperforming the benchmark BSE Sensex which has reduced by 13.18% during the same period.